Gene defect may point to solution for Alzheimer's

Gene defect may point to solution for Alzheimer's
Laurence Bindoff (picture) and Janniche Torsvik have studied the connection between the protein (PITRM1) and neurodegeneration in order to create new medicines to fight Alzheimer's disease. Credit: Solfrid T. Langeland

Alzheimer's disease is caused by protein (amyloid) deposition in the brain. New research at the University of Bergen (UiB) and Haukeland University Hospital shows that the protein PITRM1, which is found in mitochondria, otherwise known as the powerhouses of the cell, may be involved in the development of the disease.

"When the level of PITRM1 in the decreases, this leads to an increase in the deposition of protein sediment in the brain," says researcher Janniche Torsvik, at the Mitochondrial Medicine & Neurogenetics (MMN) research group at UiB's Department of Clinical Medicine (K1).

From gene defect to brain sediment

The group has investigated a family with a gene defect that leads to reduced amounts of PITRM1. The family suffered major physical and psychological problems.

"The family had reduced amounts of this PITRM1 protein and became increasingly ill. Scans of their brains confirmed the damage and when we tested mice with the same loss of PITRM1, these too had neurological problems and protein deposition in the brain," says Torsvik.

Torsvik points out that the new study is important to understand neurodegenerative diseases such as Alzheimer's .

"The results conclude a long discussion about the relationship between mitochondria and accumulation of amyloid in the . We have found that mitochondria play a crucial role in the process of protein deposition," says Torsvik.

Searching for new medication

Professor Laurence A Bindoff, who is leading the MMN group in Bergen, wants to do more research on PITRM1 and its role in other neurodegenerative diseases.

"Our aim is that this research will help us find medications to prevent or delay diseases like Alzheimer's," says Bindoff.

He wants to find out more about diseases such as Alzheimer's and has applied to become a Norwegian Centre of Excellence (SFF), a programme administered by the Research Council of Norway.

The new centre is to be called the Centre for research into age related neurodegenerative diseases (NeuroAge) and is now in the final round to get the prestigious SFF status.

The UiB researchers worked together with the neurological department at Førde Central Hospital in Norway, the centre Medical Genetics and Molecular Medicine (MGM) at Haukeland University Hospital and the MRC Mitochondrial Biology Unit at the University of Cambridge, a lab led by Massimo Zeviani.

Mitochondria

  • Mitochondria are known as the powerhouses of the cell.
  • Mitochondria exist in almost every cell of the human body.
  • If the mitochondria do not function the way they should, it can lead to serious illness.
  • In we find the PITRM1. This study show that it is a connection between reduced mitochondrial function and neurodegenerative diseases like Alzheimer`s.

Explore further

New insights into the cause of neurological symptoms in mitochondrial diseases

More information: D. Brunetti et al. Defective PITRM1 mitochondrial peptidase is associated with A amyloidotic neurodegeneration, EMBO Molecular Medicine (2015). DOI: 10.15252/emmm.201505894
Journal information: EMBO Molecular Medicine

Citation: Gene defect may point to solution for Alzheimer's (2016, April 13) retrieved 22 July 2019 from https://medicalxpress.com/news/2016-04-gene-defect-solution-alzheimer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
12 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more